Biophytis Analysis
Biophytis is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Biophytis delisted stock analysis is to determine its intrinsic value, which is an estimate of what Biophytis is worth, separate from its market price. There are two main types of Biophytis' stock analysis: fundamental analysis and technical analysis.
The Biophytis stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Biophytis is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Biophytis Stock trading window is adjusted to America/New York timezone.
Biophytis |
Biophytis Stock Analysis Notes
The company recorded a loss per share of 128.39. Biophytis had not issued any dividends in recent years. The entity had 1:40 split on the 23rd of April 2024. Biophytis S.A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases. The company was incorporated in 2006 and is headquartered in Paris, France. Biophytis operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 26 people. For more info on Biophytis please contact Stanislas Veillet at 33 1 44 27 23 00 or go to https://www.biophytis.com.Biophytis Investment Alerts
Biophytis is not yet fully synchronised with the market data | |
Biophytis has some characteristics of a very speculative penny stock | |
Biophytis has a very high chance of going through financial distress in the upcoming years | |
Biophytishas 368,955 shares shorted by Biophytis investors is about 100% of outstending shares | |
Net Loss for the year was (17.03 M) with profit before overhead, payroll, taxes, and interest of 0. | |
Biophytis currently holds about 23.93 M in cash with (13.33 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.71. |
Biophytis Upcoming and Recent Events
16th of April 2024 Upcoming Quarterly Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
16th of April 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Biophytis Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.61 M.Biophytis Outstanding Bonds
Biophytis issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Biophytis uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Biophytis bonds can be classified according to their maturity, which is the date when Biophytis has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Dana 575 percent Corp BondUS235822AB96 | View | |
MPLX LP 4125 Corp BondUS55336VAK61 | View | |
MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
MPLX LP 52 Corp BondUS55336VAL45 | View | |
BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
MGM Resorts International Corp BondUS552953CD18 | View |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Biophytis to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Money Managers Now
Money ManagersScreen money managers from public funds and ETFs managed around the world |
All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Consideration for investing in Biophytis Stock
If you are still planning to invest in Biophytis check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biophytis' history and understand the potential risks before investing.
Stocks Directory Find actively traded stocks across global markets | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |